Atabecestat
Atabecestat (JNJ-54861911) is a potent, brain-penetrant, and orally active β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor that achieves robust and high CSF Aβ reduction, is well-tolerated, and displays sustained pharmacokinetic (PK) and pharmacodynamic (PD) characteristics. Atabecestat (JNJ-54861911) has the potential for Alzheimer's Disease treatment.
Product Specifications
CAS Number
1200493-78-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
367.4
Molecular Formula
C18H14FN5OS
Notes
Research use only, not for human use.
Receptor
BACE
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GWB-D1CB2F 0.05 mg
Anti- Wingless-type MMTV Integration Site Family Member 2B (WNT2B) Human Antibody
Ask
View Details 
1217200 12 PCS/PCK
TrueNorth Cardboard Cryogenic Vial Boxes Type HS2860CB, blue PU= 12 pieces - Dimensions lxwxh: 133 x 133 x 50 mm
Ask
View Details MBS1360804-01 0.02 mg (E-Coli)
Recombinant Pseudoalteromonas haloplanktis Maf-like protein PSHAa1813 (PSHAa1813)
Ask
View Details MBS1360804-02 0.1 mg (E-Coli)
Recombinant Pseudoalteromonas haloplanktis Maf-like protein PSHAa1813 (PSHAa1813)
Ask
View Details MBS1360804-03 0.02 mg (Yeast)
Recombinant Pseudoalteromonas haloplanktis Maf-like protein PSHAa1813 (PSHAa1813)
Ask
View Details